News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

January 15, 2024

January 3, 2024

December 20, 2023

December 13, 2023

YourChoice Therapeutics Begins First-in-human Trial for Male Birth Control pill

December 12, 2023

October 30, 2023

Catalyst Biosciences Completes of Merger with Gyre Pharmaceuticals and Implements Name Change

October 12, 2023

Pulse 2.0

Pow.Bio Closes $9.5 Million To Develop Intelligent Continuous Fermentation Technologies

October 3, 2023

September 18, 2023

August 23, 2023

July 17, 2023

July 7, 2023

July 6, 2023

June 15, 2023

May 23, 2023

May 11, 2023

May 1, 2023

March 21, 2023

March 20, 2023

Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479

December 20, 2022